SRINAGAR: The Indian Council of Medical Research (ICMR), the nation’s top medical research organization is the conducting the second round of national sero-survey for COVID-19 titled ‘National sero-surveillance to monitor the trend of SARS-CoV-2 infection transmission in India: Community-based surveillance’ across 60 districts and 10 hot-spot sites among all states and union territories of the country to see the changing trend of population response to SARS COV-2 infection over these months since the first round was held in May and June this year where the prevalence of IgG antibody titres were found 0.73% among the general population in the country, an official statement said.
According to a statement issued by GMC Srinagar said that in the second round, the data will again be collected through app-based and blood samples will be taken to assess immunoglobulin-Gamma (Ig-G) against SARS-CoV-2 which will determine infection in recent past and the body’s immune response to the SARS CoV-2 infection. Each selected site collects data and blood samples of 400 participants of children over 10 years and adult population.
ICMR is conducting the study through its regional centres, however, the Director-General ICMR & Secretary, Department of Health Research, MOHFW, Government of India Dr Balram Bhargava again asked Government Medical College, Srinagar to conduct the study in Pulwama district on its behalf for which it has communicated to Atal Dulloo, financial commissioner, health and medical education department, J&K.
“A team from Government Medical College Srinagar comprising faculty, resident doctors and medical interns from Department of Community Medicine (SPM) are deputed by Dr Samia Rashid, principal/ dean, GMC Srinagar for conducting the survey in ICMR assigned ten clusters in district Pulwama with full support and cooperation from Deputy Commissioner Pulwama Dr Raghav Langer, Chief Medical Officer, Pulwama Dr Hassina Mir and health teams including doctors, laboratory technicians and other paramedical staff at district level while ICMR Headquarter New Delhi, and its premier centres including National Institute of Epidemiology (NIE), Chennai is providing support in training, guidance, ELISA testing, data management, analytics and logistics support,” said Dr S Muhammad Salim Khan, HOD Community Medicine, GMC Srinagar and nodal person for ICMR national ser-survey for COVID-19 of district Pulwama. The blood samples will be sent to ICMR lab at Chennai.
In the first round, the sero-prevalence in district Pulwama was found to be 2% which was higher than the national average of 0.73% while the recent study by GMC Srinagar in district Srinagar showed the prevalence of 3.8% among the general population which is almost twice than the prevalence in district Pulwama. However, this time the seroprevalence is expected to be more than the previous outcome, said the statement issued by GMC Srinagar.
